Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, announced the appointment of Steven R. Steinhubl, MD, as Chief Medical Officer (CMO) and member of the executive leadership team.

As Chief Medical Officer, Dr. Steinhubl will help drive Eko’s clinical strategy, research initiatives, and external scientific collaborations, further strengthening the evidence base and accelerating AI adoption across health systems worldwide. His multidisciplinary background spanning engineering, physiology and medicine uniquely positions him to bridge technology innovation with practical clinical application.

“As a clinician and researcher, I’ve long believed that the future of cardiovascular care lies in combining high-fidelity physiological data with intelligent analytics delivered seamlessly at the point of care,” said Dr. Steinhubl.

Also read: Singapore Diagnostics wins two awards at Healthcare Asia Awards 2026

Dr. Steinhubl currently serves as the Vincent P. Reilly Professor of Biomedical Engineering at Purdue University in the Weldon School of Biomedical Engineering and is a member of the Regenstrief Center for Healthcare Engineering in West Lafayette, Indiana. A globally recognized cardiologist, clinical researcher, and digital medicine pioneer, Dr. Steinhubl has dedicated his career to advancing cardiovascular care through the integration of wearable technologies, artificial intelligence, and virtual-first care models.

Click here to join our WhatsApp channel here

“Steve understands both the clinical realities of cardiovascular care and the promise of new technologies to improve it,” said Connor Landgraf, co-founder and CEO of Eko Health. “As Eko expands the global reach of AI-powered cardiac detection, his leadership will help ensure our work continues to translate into meaningful outcomes for clinicians and the patients they serve.”